11/8/2018
1
Pain Management in the Neonate
Tanya Hatfield, MSN, RNC-NICNeonatal Outreach Educator
▪Wide variation in medical personnel’s beliefs and knowledge about pain▪Parents have anxiety around the use of opiates and sedatives (narcotics)▪General public concern over “addiction” to pain medications
Attitudes
11/8/2018
2
▪Attitudes of nurses, physicians, parents and ancillary staff must be evaluated to identify current beliefs▪Attitudes can be a barrier to successful implementation of this program as with any other multifaceted program▪Have you had an experience where provider attitudes were conflicting?
Attitudes
▪The pain pathways in neonates are unmyelinated or otherwise immature and cannot transmit painful stimuli to the brain.▪Pain perception is located only in the cortex, and thalamocortical connections must be fully developed in order to allow pain perception.▪The human infant does not have the psychological context in order to identify any experiences as painful and this does not develop until two years or later.▪Newborn infants are at greater risk for developing the adverse effects of analgesic or sedative agents, or these drugs have adverse long-term effects on brain development and behavior.
Misconceptions
11/8/2018
3
▪What is your own experience of pain?▪What pain medications or sedatives have you taken?▪Have you had good or bad feeling when given a sedative or opiate?▪Have you had a patient with an adverse effect that led to a serious consequence?
Personal Experience
▪Pain▪Stress▪Stress or pain response▪Analgesia▪Pain control▪Types of pain: acute, established, chronic
Definitions
(Anand et al, 2006)
11/8/2018
4
▪Fetal Development▪Neonatal vs adult pain▪Developmental responses▪Pain Pathways
•Ascending•Descending
▪“Behind the Heel Lance” Minyan Wang, 2012
Physiology of Pain
▪Large, prospective study of 430 infants
▪All painful, stressful procedures for first 14 days recorded
▪70,000 first attempt procedures
▪11,500 supplemental attempts
▪Median of 115 procedures
▪Of the 42,413 painful procedures, analgesia was provided in 20.8 percent of patients (34 percent received concurrent analgesia)
•nonpharmacologic therapy (18 percent)
•only pharmacologic therapy (2 percent)
•both nonpharmacologic and pharmacologic therapy (0.4 percent)
Epidemiology and treatment of painful procedures in neonates in intensive care units (Carbajal et al., 2008)
11/8/2018
5
Effects of inadequate analgesia▪Gastrointestinal
•↓’d gut motility•Delay in return of bowel function
▪Genitourinary•↓’d urine output•Urinary retention•Potential for fluid overload
• Cardiovascular• ↑’d heart rate• ↑’d blood pressure• ↑’d cardiac output • hyper coagulation
• Pulmonary• ↓’d tidal volume• ↓’d cough• ↑’d splinting• Hypoxia• Atelectasis
•Immune System–Impaired immune function–Exaggerated stress response
•Metabolic–Hyper metabolism–Decreased insulin secretion–Protein catabolism–Metabolic acidosis–↓’d glucose stores (especially neonates)
Effects of inadequate analgesia
11/8/2018
6
Pain Signs
•Elevated HR
•HR lower than baseline
•Loss of HR variability
•Elevated CO2
•Increased respiratory rate
•Lower saturations
•Elevated temperature
•Knees drawn up
•Cries with handling
•Limbs stiff
•Jumpy/jittery
•Crying volume louder
•Increased crying
•Elevated BP
•Metabolic Acidosis
•Grimace with handling
•Grimace undisturbed
•Furrowed brow
•Restless while sleeping
•Stiffens with handling
•Whimpering
•Hypoventilation
•Clenched hands/feet
•Pale/mottled/cyanotic
•Reduced movement
•Lack of quiet alert state
•Cool skin/Temp ok
•Higher pitched cry
•Unusual silence
•Disturbed sleep
•Excessive sleep
•Elevated blood glucose
•Curled toes
•Stiff body
“Pain Signs Survey”Rating of signs to Assess Pain in Neonates
▪Physiologic indicators-rated as #1 Used Often•Increased HR-85%•Increased BP-88%
▪Behavioral Indicators-rated as #1 Used often•Curled toes-65%•Clenched hand and feet-68%
•Facial grimace with handling-79%
11/8/2018
7
▶ Change in respirations
▶ Increase/decrease blood pressure
▶ Increase/decrease in heart rate
▶ Loss of HR variability
▶ Color change▶ Decreased skin
perfusion-pallor and mottling
▶ Decrease in oxygen saturation
▶ Palmar sweating
Physiologic Responses to PainClinical J Pain, 26 (9) 2010
▪ Altered pain response• May lead to increased pain sensitivity and/or
chronic pain syndromes▪ Neurodevelopmental outcome
• Frequent exposure to pain-related stress has been correlated with impaired:
‒ Cognitive development, altered neurocognitive processing, decreased cortical thickness, dysregulation of the hypothalmic-pituitary-adrenal (HPA) axis
Effects of inadequately treated pain
Anand KJ, Scalzo FM. Can adverse neonatal experiences alter brain development and subsequent behavior? Biol Neonate 2000; 77:69.
11/8/2018
8
▪Multiple tools exist▪Some use only behavioral indicators such as cry or tone▪Others use physiologic indicators such as HR and blood pressure▪Some use a combination of both▪In a setting with monitoring, use a tool with physiologic indicators
Pain Assessment Tools
▪Non-verbal population▪Lack of consensus in health care providers▪Physiologic changes that are compatible with condition/disease as well as pain-THINK PAIN▪Parents less likely to have knowledge of infant’s pain behaviors▪Prolonged effect of neuromuscular blockade ▪Extreme prematurity or critically ill patients▪Persistent or prolonged pain
Barriers to Assessment
11/8/2018
9
▪FLACC- one dimensional▪NIPS- behavior, state, tone, pattern of respiration▪CRIES- behavior /physiologic-Term Post-op▪N-PASS- behavioral, physiologic, credit for immaturity, allows sedation assessment▪COMFORT- behavior and physiologic-nonverbal post-op critical care▪PIPP- gestational based, state, facial expression, saturation change
Pain Tools
11/8/2018
10
FLACC
NIPS Scale
(Hudson-Barr et al., 2002)
11/8/2018
11
CRIES Scale
(KRECHEL, & BILDNER, 1995)
11/8/2018
12
▪Select a box that describes the infant for each category in the pain section▪Range is 0-10▪Cannot be used if infant paralyzed▪Credit given for very immature infants▪Limits-no category for “shut down”
N-PASS
Assessment Criteria
Sedation Normal Pain/Agitation
-2 -1 0 1 2
Crying Irritability
No cry with painful stimuli
Moans or cries minimally with painful stimuli
Appropriate crying Not
irritable
Irritable or crying at intervals Consolable
High-pitched or silent continuous cry Inconsolable
Behavior State
No arousal to any stimuli No spontaneous
movement
Arouses minimally to stimuli Little spontaneous movement
Appropriate for gestational age
Restless, squirming Awakens frequently
Arching, kicking Constantly awake or arouses
minimally/no movement/not
sedated
Facial Expression
Mouth is lax No expression
Minimal expression with
stimuli
Relaxed Appropriate
Any pain expression intermittent
Any pain expression continual
Extremities Tone
No grasp reflex Flaccid tone
Weak grasp Decrease muscle
tone
Relaxed hands and feet Normal
tone
Intermittent clenched toes, fist, or finger
splay Body is not tense
Continual clenched toes, fist, or finger
splay Body is tense
Vital Signs HR, RR, BP,
Sa02
No variability with stimuli
Hypoventilation or apnea
<10% variability from baseline with stimuli
Within baseline or normal for
gestational age
Increase 10-20% from baseline Sa02 76-85%
with stimulation-quick increase
Increase >20% from baseline
Sa0s < 75% with stimulation- slow increase Out of sync with vent
11/8/2018
13
▪Useful for post-procedural pain▪Ages 0-18 yrs
COMFORT pain scale
PIPP scale
11/8/2018
14
Pain Assessment in Neonates
Classic Pain Faces Shutdown
Nasolabial furrow
Mouth open
Brow bulge
Broaden nose and bulging
Eye squeeze
Assessment of Functional Capacity•Very few Pain Tools incorporate the concept of “Shutdown” in assessment•All infants move and have tone•Severe pain is associated with a patient who does not move, has decreased tone and does not have “social contact”
11/8/2018
15
▪Dependent on skill, and attitude of caretaker ▪Adequacy of a tool to improve objectivity▪Evaluation time may cross over two caretakers (shift change)▪What drug and dose was right for last week may not be adequate for this week and this circumstance
Evaluation of Treatment
“Pain Assessment should be comprehensive and
multidimensional, including contextual, behavioral and
physiological indicators”Dr. K.J.S. Anand
VON Pain CollaborativeContent Expert
11/8/2018
16
“Think outside the Tool”
▪Use all the information that is available to you▪If there is a clear pain source, treat it▪Do not wait for the score to be high, preempting pain will require less drug
“We rule out sepsis, why can’t we rule out pain?”
11/8/2018
17
What is painful?
Commonly Performed Procedures:Mild Invasiveness
▪Physical exam▪Insertion of gavage tube▪UAC/UVC placement▪Cultures▪Bladder catheterization▪Eye culture▪Hearing screen
Brittingham, L. (2015). Mitigating Procedural Pain in High-Risk Infants: Challenges and Opportunities. Presentation, Dandle-LION webinars.
11/8/2018
18
Commonly Performed Procedures:Moderate Invasiveness
▪Arterial Puncture▪Venipuncture▪Heel stick▪Tracheal Suctioning▪Intubation▪Intramuscular Injection
Brittingham, L. (2015). Mitigating Procedural Pain in High-Risk Infants: Challenges and Opportunities. Presentation, Dandle-LION webinars.
▪CVL removal▪Thoracentesis▪Surfactant Administration▪Suture removal▪Extubation▪Ventricular Tap
Commonly Performed Procedures:Severe Invasiveness
▪Arterial/venous cutdown
▪Arterial Catheterization
▪Circumcision
▪Lumbar Puncture
▪Eye exam for ROP
▪Bronchoscopy or Endoscopy
▪Suprapubic Bladder Tap
▪CVL placement
▪Chest Tube Placement
Brittingham, L. (2015). Mitigating Procedural Pain in High-Risk Infants: Challenges and Opportunities. Presentation, Dandle-LION webinars.
11/8/2018
19
Pain Management Analgesia▪Nonpharmacological measures▪Pharmacological measures
•Topical Anesthetics•Oral, IV or rectal acetaminophen•Slow IV infusion of opioids•Subcutaneous lidocaine or nerve blocks•Deep sedation or general anesthesia
Principles of Pain Management
▪Environmental, behavioral, non-pharmacologic interventions are the foundation of pain management▪Pharmacologic pain intervention is additive▪Combination of non-pharmacologic with pharmacologic measures minimizes pain/stress & maximizes self-regulatory capacities
11/8/2018
20
Nonpharmacological measures▪Breastfeeding▪Non-nutritive sucking▪Swaddled or facilitated tucking▪Skin-to-skin contact▪Sensorial saturation▪Massage▪Environmental
Pharmacological measures
▪Oral Sucrose or Glucose•Reduced crying time•Dampened physiologic responses•Reduced facial expression•Lower pain scores
11/8/2018
21
Oral Sucrose & Glucose
▪Proposed mode of action▪Clinical use▪Dosing and administration
•Onset of action is 10 seconds•Peak action is 2 minutes•Duration of action is 10 minutes
▪Analgesic effects-primarily mediated through opioid pathways▪Efficacy-supported in many studies over the past decade AAP/CPS support▪Safety-No adverse effects reported except choking in very low birth weight infants▪24% solution is hyperosmolar but has been shown to not grow bacteria, or fungus
Sucrose for Procedural PainLinda Franck, Children’s Medical Ventures Educational Booklet, Vol1,N0.1,2000.
11/8/2018
22
▪Dose and mode of delivery-varies▪NG administration is not effective▪Felt to be synergistic with non-nutritive sucking▪Drops as needed-repeat during procedure ▪Heel stick, venipuncture, immunization, tape removal, NG insertion, dressing changes, bladder catheterizations etc.▪Non-procedural use- Pain behaviors that cannot be managed with interventions such as diaper change etc.
Sucrose for Procedural Pain
11/8/2018
23
Topical AnestheticsBiran, V. et al, “Analgesic effects of EMLA cream and oral sucrose during venipuncture in preterm infants”. Pediatrics 2011; 128:e63.
•Pain behaviors reduced as an adjunct to nerve block in circumcision•Reduced pain in venipuncture and arterial puncture•No effect on heel stick•Reduced pain in spinal tap•Mild transient skin irritation is rare•Application requires occlusion-LMX 20 minutes, EMLA 60 minutes•Level of anesthesia for 45-60 minutes
▪Acetaminophen-10-15 mg/kg PO q4-8 hr.
▪Acetaminophen-15-20 mg/kg PR q4-8 hr.
▪Acetaminophen 15 mg/kg IV q 4-6 hr.
(All acetaminophen should be ordered based on a daily max safe dose)
▪Ketorolac (not much data)-0.5 mg/kg/dose, 2-4 doses a day
Non-Opiate Therapy
11/8/2018
24
Pain Management IV Tylenol
▪Current dosing recommendation:•Load with 20 mg/kg IV over ~15 minutes•10 mg/kg IV every 6 hours-longer interval in premature infants
▪New FDA approval in the US, used in Europe for over a decade▪Not much published compatibility data ▪Does not mask fever▪No reports of hepatic injury when used for post-operative pain management
Effect of IV Paracetamol on Postoperative Morphine Requirements in Neonates and Infants Undergoing Major Noncardiac Surgery Ceelie, She, et al, JAMA, 2013; 309 (2)
▪71 Neonates in an Intensive Care Unit▪Loaded with morphine 30 minutes before the end of surgery▪Randomized to continuous morphine or intermittent IV Tylenol for 48 hours after surgery
•Cumulative morphine dose in Tylenol group was 121 (99-264 mcg/kg)
•Cumulative morphine dose in the non Tylenol group was 357 (220-605 mcg/kg)‒P<.001 between groups
11/8/2018
25
Lidocaine-1%
▪Local instillation effective for:•Venipuncture or arterial puncture•Circumcision•Infiltration of incision site preoperatively•Chest tube insertion•Tap procedures for fluid-peritoneal or pleural•Toxicity can occur if used in high doses and multiple sites
▪Morphine remains the standard against which new analgesics are measured▪The drug is still obtained from opium or extracted from poppy straw▪Morphine produces its major effect on the CNS by acting as agonists to mu receptors▪There is no upper limit
•However, hyperanalgesia can occur
Morphine and Related Opioids
11/8/2018
26
▪Respiratory depression-direct effect on brainstem respiratory centers▪Therapeutic doses rarely effect blood pressure, cardiac rate and rhythm▪Histamine release may lead to hypotension-rare in young infants▪Blunts reflex vasoconstriction caused by increased PCO2
Morphine Pharmacokinetics
▪Opiates and sedatives are cleared slower in an immature infant▪Clearance improves with post conceptual age, reaches adult levels at about 1 month▪Amount of drug needed to achieve goal increases with time (tolerance)▪There are significant individual differences
Pharmacokinetics “The Moving Target”
11/8/2018
27
▪20 infants studied, 26-40 Weeks▪Given a single dose of Morphine 0.1mg/kg▪Distribution half-life: Preterm vs Term▪ 50+-35 minutes/19 +- 8 minutes▪Elimination half-life: Preterm vs Term 10+- 3.7 hours/6.7+-4.8 hours
Single Dose MorphinePharmacokinetics in PrematuresBhat,R. et al, J Peds, 1990.
▪26 non-cardiac/major surgery, > 36 Wk.▪Continuous post-op infusions, levels checked once steady state achieved▪Clearance mean in:
•1-7 day olds 9.2 mL/min/kg, •31-90 days 25.3 mL/min/kg, •91-180 49.9 mL/min/kg
Morphine Clearance in Post-Op Infants
11/8/2018
28
▪Conclusions:•Adult clearance values were reached by 1 month of age
•Clearance was faster than previous studies looking at post-op cardiac surgical infants
Morphine Clearance in InfantsLynn, A. et al, Anesth. Analg. 1998:86:958-63.
▪30 ventilated Infants 27-31 wk., 800-1680 grams▪Loaded 100 mcg/kg/h for 2 hours▪No change in cerebral or cardiac Doppler parameters▪MAP 44 +- 6 mmHg fell to 42+-4
•down 4%▪HR 148+-12 fell to 140 +-16
•down 5%
Hemodynamic Effects of IV Morphine
11/8/2018
29
▪Summary: A loading dose of morphine over 2 hours did not have any significant effect on MABP or cerebral and cardiac hemodynamics▪No Adverse effects were noted that could be attributed to morphine therapy
Hemodynamic Effects of IV MSSabatino, et al, early Human Development, 47, (1997)
▪Morphine-.05-.1 mg/kg/dose IV •Repeat every 4 hours as needed
▪Continuous infusion:•Loading 0.1 mg/kg infused slowly (1hour) •Continuous drip 0.015-.02 mg/kg/hour
▪There is no limit▪Doses will need to be adjusted based on effect, age, duration of drug and maturity
Neonatal Dosing
11/8/2018
30
▪Use lower dose in non-ventilated infants▪Have Narcan available▪Increase pressers or give volume if blood pressure falls▪Give the dose slowing the first time, prepare for but do not assume adverse reaction
Practical Tips/Morphine Use
▪Total body clearance 17 +- 4.3 ml/kg/min▪Elimination half-life 317+-70 minutes▪Highly variable in all infants▪Dosing
•0.5-2 mcg/kg/dose IV •Repeat every 1-2 hours
•Adjunct to anesthesia •Infusion- 1mcg load and 0.5 mcg/kg/hr-.4 mcg/kg increase to effect
•Doses will need to be varied based on age
Fentanyl Pharmacokinetics in InfantsKoentop, D. et al.
11/8/2018
31
▪Start with low doses in more at risk infants▪Use for shorter duration of procedure▪If chest wall rigidity occurs, reverse with Narcan/paralytic▪Consider in hypotensive infants or those who have histamine effect with morphine
Practical Tips/Fentanyl
“Sedatives and Opiates are unique in that their adverse
effects can be reversed rapidly.”
11/8/2018
32
▪Specific Opioid antagonist, nonselective▪Reverses desired and undesired effects▪Half life shorter than morphine, may need to be repeated▪Intermittent small doses .05-.1 mg/kg to reverse unacceptable effects with little change in desired effects
Naloxone
▪Romazicon- 10 mcg/kg IV▪Reverses CNS effects with 2 minutes▪Sedative antagonist
Flumazenil
11/8/2018
33
▪Midazolam•Short acting benzodiazepine•Increased sedation•Increase in poor neurological outcomes in preterm infants
▪Lorazapam▪Ketamine
What do we know about sedatives?
Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Pediatr Adolesc Med 1999; 153:331.
▪Review and reduce need for noxious procedures▪Use pharmacologic agents for the ones that cause pain-chest tubes, LP’s▪Nonpharmacologic measures for minor procedures▪Topical analgesics-EMLA/J-tip▪Combination of therapies
Procedural PainSeminars in Perinatology, 22.5, 1998.
11/8/2018
34
▪Develop consensus ▪Write treatment protocol including premedication, dose, monitoring, assessment▪Plan ahead
Procedural Pain Management
▪Oral sucrose▪Containment▪Vein selection-hands more painful than antecubital▪When frequent blood draws are required consider a short term access such as an umbilical catheter or peripheral arterial line-Risk/Benefit discussion▪Batching of all lab draws-coordination of orders to reduce sticks
IV Start/Venipuncture
11/8/2018
35
PICC Insertion
▪Topical Lidocaine▪Low dose opiate▪Containment▪Oral sucrose
Spinal Tap/Lumbar Puncture
▪Topical Lidocaine▪Lidocaine instillation ▪Low dose opiate ▪Low dose sedative▪Goals are patient comfort and ease of positioning to improve success of procedure
11/8/2018
36
Chest Tube Insertion
▪Lidocaine instillation-0.5 ml-1% solution without epinephrine no more than 3-5 mg/kg▪Opiate IV-lower dose if not intubated▪Consider more opiate for chest tube removal▪Some pain source during duration of indwelling tube during handling and breathing
ROP LaserSammartine, M. et al, “ Efficacy and safety of continuous intravenous infusion of remifentanil in preterm infants undergoing laser therapy in retinopathy of prematurity: clinical experience” Paediatr Anaesth 2003; 13: 596.
▪Topical anesthetic (proparacaine), oral sucrose and comfort care (containment) show minimal or no effects on pain behaviors▪Deep sedation recommended with short acting drugs like midazolam and fentanyl are most effective▪Consider orders for Romazicon and Narcan after the procedure is completed if sedation leads to apnea, bradycardia or desaturations▪Doses will need to be repeated due to the half life of the reversal agents compared to the drugs
11/8/2018
37
IntubationAAP Committee on Fetus and Newborn, Section on Anesthesiology and Pain Medicine, 2010
▪Recommend premedication for nonemergency intubation in neonates
•Number of attempts reduced•Time to intubation reduced•Minimizes airway trauma
▪Improved physiologic homeostasis-less bradycardia, desaturations, less increased in intracranial pressure
Intubation-Premedication▪Initial medication:
•Fast acting opiate: Fentanyl 2 mcg/kg given by slow IV push to avoid chest wall rigidity
▪Second medication•Atropine 20 mcg/kg IV, wait for a 20 bpm risk in heart rate, blunts the vagal response and reduces secretions
▪Last medication: •Fast acting neuromuscular blockade agent-Rocuronium 1 mg/kg or Succinylcholine 2 mg/kg IV push-given when ready to insert tube (in hand/positioned)-duration 1 hr.-4-6 minutes
11/8/2018
38
Other Procedures➢ETT Suctioning ➢NG insertion➢Bladder catheterization➢Dressing changes➢Heel sticks➢Eye exams➢IM or SQ injections➢Imaging procedures➢Reduce number of events with no routines
11/8/2018
39
11/8/2018
40
Examining the New Research-Efficacy and Safety
NOPAIN TrialArch Pediatr Adolesc Med, 1999: 331-338▪To define the incidence of clinical outcomes in the target study population, and adverse effects associated with analgesia and sedation, and to calculate the sample size or a definitive test of this hypothesis▪67 infants 24-32 weeks from 9 centers▪Ventilated infants▪Randomized to :
•Continuous infusions of morphine sulfate•Continuous infusions of Midazolam •Continuous infusions of 10% dextrose
11/8/2018
41
NOPAIN Trial▪Monitored for:
•Level of sedation (Comfort Score)•Responses to pain-PIPP•Cranial ultrasounds•Examined for poor neurologic outcomes:
‒Death‒Severe IVH (III or IV)‒Periventrivcular leukomalacia
NOPAIN Trial Results
▪Death-1 in Midazolam and placebo group▪Poor outcomes:
•24% in placebo group•32% in Midazolam group•4% in morphine group
▪PIPP scores reduced in the morphine group
11/8/2018
42
NOPAIN Trial Results▪Analgesia given by continuous low-dose morphine infusion may reduce the incidence of poor neurologic outcomes in preterm neonates who require ventilatory support
▪Cannot be recommended for all infants (uptodate.com, 2017)
NEOPAIN StudyNeurologic Outcomes and Pre-emptive Analgesia
in Neonates
11/8/2018
43
NEOPAIN Randomized TrialAnand, KJS, et al, Lancet, 2004.▪898 infants, randomly assigned to placebo or morphine infusions▪Loading dose of morphine 0.1 mg/kg then:➢0.01 mg/kg/hr 23-26 weeks➢0.02 mg/kg/hr 27-29 weeks➢0.03 mg/kg/hr 30-32 weeks
➢Continued as long as clinically justified, max of 14 days
NEOPAIN Randomized Study
▪Open label morphine could be given on clinical judgment
•242/443 in morphine group•202/446 in placebo group
▪Similar death rates-11% vs 13%▪Severe IVH 11% vs13%▪PVL 9% vs 7%
11/8/2018
44
NEOPAIN StudyAnand et al, Lancet, 2004.▪Placebo-group neonates receiving open label morphine had worse rates of composite outcome that those not receiving open label morphine p<0.0001
▪Morphine group neonates receiving open-label morphine were more likely to develop severe IVH 19% vs 9% p=0.0024
Morphine, Hypotension, and IVH in Ventilated Premature InfantsHall, R.W. et al Pediatrics Vol.115, No.5 2005.
▪Objective: •To provide secondary data analysis from the NEOPAIN trial
•Identify clinical factors associated with hypotension
•Examine the contributions of morphine treatment or hypotension in severe IVH
11/8/2018
45
Secondary Data Analysis NEOPAIN StudyNEOPAIN Trial Investigators Group, Pediatrics 2005.
▪Hypotension was associated with: •23-26 weeks of gestation•Morphine infusions•Severity of illness•Additional morphine doses•Prior hypotension
▪Morphine infusions were not a significant factor in logistic models for severe IVH, any IVH or death
Outcome at 5-6 years of prematurely born children who received morphine as neonatesMacGregor, Ruth et al Arch Dis Child Fetal Neonatal Ed 1998.
▪87 children were assessed at age 5-6 years who had been previously less than 34 weeks and randomly assigned to receive morphine or non-morphine treatment as neonates
•No differences in the groups with trend “towards better performance” in all three tests in the morphine group
11/8/2018
46
Measuring preterm cumulative stressors within the NICU: the Neonatal Infant Stressor Scale.(Newnham CA1, Inder TE, Milgrom J., 2009)
▪Aimed to quantify the severity of common stressors for preterm infants▪Created tool to manage presumed accumulated infant stress
▪If a baby had a score of 6 in a 2 hour period, no one could touch the baby
Neuro-developmental Care
92
11/8/2018
47
NISS scores
93Smith, G., Gutovich, J., Smyser, C., Pineda, R., Newnham, C., & Tjoeng, T. et al. (2011). Neonatal intensive care unit stress is associated with brain development in preterm infants. Annals Of Neurology, 70(4), 541-549. http://dx.doi.org/10.1002/ana.22545
Pre-emptive Analgesia in the NICUGrunau, R.E. et al, Seminars in Fetal and Neonatal Medicine 2006
“It is very challenging to study effects of morphine or other analgesics or sedatives used pre-emptively in the NICU, even in RCT’s, because humane care of infants
currently requires physicians to treat those thought to be in pain, despite the knowledge gaps of long-term risks and benefits of these
medications.”
11/8/2018
48
Summary Proceedings From the Neonatal Pain Control GroupAnand, K.J.S. et al, Pediatrics, VOl.117, No.3, March 2006
▪Pain control measures are adopted infrequently because of unresolved scientific issues and lack of appreciation for the need for control of pain and its long-term sequelae during the critical phases of neurologic maturation in the preterm and newborn infant.
Offsetting stress & pain with POSITIVE experiences
▪Stressful experiences in NICU are inevitable▪How do we provide positive experiences?
•Tactile•Vestibular•Gustatory•Olfactory•Auditory•Visual
▪How do we document this?96
11/8/2018
49
Summary▪Sick, premature infants undergo multiple painful procedures▪Pain management during invasive procedures and post-operatively should be a standard in neonatal care▪Routine use of sedatives and or opiates in the absence of a painful procedure is not currently recommended▪Study design will remain problematic due to difficulties in control and the clear obligation to treat pain in infants
Summary
▪There is no clear evidence that the use of opiates in neonates causes adverse neurodevelopmental outcomes▪All sedative and opiate use should be carefully considered in light of the behavior in the infant and the source of the behavior▪It is our professional duty to treat pain behaviors and preempt procedural and postoperative pain
11/8/2018
50
“Treating Pain in neonates is the right thing to do and is our job. We may not have all the answers but we can begin by advocating for every infant in our care and work towards a consensus and safe practice.”
▪Hudson-Barr, D., Capper-Michel, B., Lambert, S., Mizell Palermo, T., Morbeto, K., & Lombardo, S. (2002). Validation of the Pain Assessment in Neonates (PAIN) Scale with the Neonatal Infant Pain Scale (NIPS). Neonatal Network: The Journal Of Neonatal Nursing, 21(6), 15-21. http://dx.doi.org/10.1891/0730-0832.21.6.15
▪KRECHEL, S., & BILDNER, J. (1995). CRIES: a new neonatal postoperative pain measurement score. Initial testing of validity and reliability. Pediatric Anesthesia, 5(1), 53-61. http://dx.doi.org/10.1111/j.1460-9592.1995.tb00242.x
References